House Speaker Paul Ryan is leaving Congress at the end of the year without success on spending cuts to Medicare, Medicaid, and Social Security; the FDA is conducting a criminal investigation into research by a Southern Illinois University professor who injected people with his unauthorized herpes vaccine; the National Institutes of Health (NIH) is "aggressively" looking into reports that it solicited funding from the alcohol industry for a study on the benefits of moderate drinking.
With House Speaker Paul Ryan, R-Wisconsin, leaving Congress at the end of the year, the Republican party will lose its most influential champion for spending curbs to Medicare, Medicaid, and Social Security, The Wall Street Journal notes. Ryan saw his party fail to repeal the 2010 Affordable Care Act even though Republicans gained control of the House, Senate, and White House for the first time in a decade in 2016. Social Security and healthcare programs are popular with voters and few lawmakers are interested in tackling the issue.
The FDA is conducting a criminal investigation into research by a Southern Illinois University (SIU) professor who injected people with his unauthorized herpes vaccine, Kaiser Health News has learned. SIU professor William Halford injected participants with his experimental herpes vaccine without routine safety oversight, typically performed by the FDA or an institutional review board. Halford died in June. The probe is looking into whether anyone from SIU or Halford’s former company, Rational Vaccines, violated FDA regulations.
The NIH is "aggressively" looking into reports that it solicited funding from the alcohol industry for a study on the benefits of moderate drinking, The Hill reported.
The New York Times has reported that NIH officials solicited donations from alcoholic beverage manufacturers to fund a $100 million study on the health effects of moderate alcohol consumption. NIH Director Francis Collins told lawmakers on Capitol Hill he has convened a “working group” and will turn anything that seems “inappropriate” over to authorities.
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More